Trials / Sponsors / Arch Biopartners Inc.
Arch Biopartners Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardia Acute Kidney Injury, Cardiac Surgery | Phase 2 | 2024-03-08 |
| Completed | LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID- COVID, Severe Acute Respiratory Syndrome, Sars-CoV2 | Phase 2 | 2020-10-14 |
| Completed | A Phase I Study to Evaluate LSALT Peptide None - Study is to Determine Safety in Healthy Participants | EARLY_Phase 1 | 2019-06-27 |